Leaderboards/Neurological Disorders and Treatments

Neurological Disorders and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Barbara Hollunder
Circuit Therapeutics (United States)
2
Ro’ee Gilron
University of California System
3
Varvara Mathiopoulou
Humboldt-Universität zu Berlin
4
Maryam Adenike Salaudeen
Ahmadu Bello University
5
Christoph Wiest
National Hospital for Neurology and Neurosurgery
6
Nicholas N. Foster
University of Southern California
7
Arjun Balachandar
University of Toronto
8
Johannes L. Busch
Charité - Universitätsmedizin Berlin
9
Roxanne Lofredi
Humboldt-Universität zu Berlin
10
Ann‐Kathrin Schalkamp
UK Dementia Research Institute

Papers

1
Mapping dysfunctional circuits in the frontal cortex using deep brain stimulation
Nature Neuroscience|2024
162 cit.
2
Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones
Biomolecules|2024
146 cit.
3
Modulation of subthalamic beta oscillations by movement, dopamine, and deep brain stimulation in Parkinson’s disease
npj Parkinson s Disease|2024
90 cit.
4
Publication in Brain stimulation (2024) [42 citations, W4391089843]
Brain stimulation|2024
42 cit.
5
Gamma entrainment induced by deep brain stimulation as a biomarker for motor improvement with neuromodulation
Nature Communications|2025
26 cit.
6
Publication in npj Parkinson s Disease (2025) [24 citations, W4413806969]
npj Parkinson s Disease|2025
24 cit.
7
Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease
npj Parkinson s Disease|2024
15 cit.
8
Publication in Movement Disorders (2024) [11 citations, W4401824487]
Movement Disorders|2024
11 cit.
9
Striato-pallidal oscillatory connectivity correlates with symptom severity in dystonia patients
Nature Communications|2024
7 cit.
10
Publication in Neurology (2025) [7 citations, W4415085436]
Neurology|2025
7 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Huiling Tan
MRC Brain Network Dynamics Unit
2
Erin K. Purcell
Quantitative BioSciences
3
Edward J. Wild
Huntington's Disease Association
4
Tara L. Skarpaas
Johns Hopkins University
5
Alexandra Nelson
University of California, San Francisco
6
Matteo Bologna
Istituto Neurologico Mediterraneo
7
Laleh Golestanirad
Northwestern University
8
Natàlia Vilor‐Tejedor
Radboud University Nijmegen
9
Wolf‐Julian Neumann
Charité - Universitätsmedizin Berlin
10
М. А. Исаков
Endocrinology Research Center

Papers

1
The aperiodic exponent of subthalamic field potentials reflects excitation/inhibition balance in Parkinsonism
eLife|2023
107 cit.
2
Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease
eLife|2022
84 cit.
3
Redefining Bradykinesia
Movement Disorders|2023
81 cit.
4
Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice
eLife|2022
55 cit.
5
Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson’s disease
Brain|2023
55 cit.
6
Shared pathway-specific network mechanisms of dopamine and deep brain stimulation for the treatment of Parkinson’s disease
Nature Communications|2025
46 cit.
7
Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
Brain Communications|2022
45 cit.
8
Longitudinal study of clinical and neurophysiological features in essential tremor
European Journal of Neurology|2022
39 cit.
9
Huntington’s Disease Clinical Trials Corner: August 2023
Journal of Huntington s Disease|2023
37 cit.
10
Brain transcriptomic profiling reveals common alterations across neurodegenerative and psychiatric disorders
Computational and Structural Biotechnology Journal|2022
36 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Andrew J. Lees
Centre for Movement Disorders
2
Peter Brown
Aneurin Bevan University Health Board
3
Andrés M. Lozano
University of Toronto
4
Yves Agid
Sorbonne Université
5
David J. Brooks
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas
6
Mahlon R. DeLong
Emory University
7
Michael R. Hayden
University of British Columbia
8
David Eidelberg
Northwell Health
9
Joseph Jankovic
Baylor College of Medicine
10
Mark Hallett
National Institute of Neurological Disorders and Stroke

Papers

1
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
Journal of Neurology Neurosurgery & Psychiatry|1992
10.4k cit.
2
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Science|1982
3.6k cit.
3
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Brain|1991
3.5k cit.
4
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.
PubMed|1990
2.5k cit.
5
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Science|1990
1.9k cit.
6
Identifying true brain interaction from EEG data using the imaginary part of coherency
Clinical Neurophysiology|2004
1.8k cit.
7
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Annals of Neurology|1981
1.7k cit.
8
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Nature Genetics|1999
1.7k cit.
9
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex
Brain|1994
1.5k cit.
10
Modulation of muscle responses evoked by transcranial magnetic stimulation during the acquisition of new fine motor skills
Journal of Neurophysiology|1995
1.4k cit.

Reagents for Neurological Disorders and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Santa Cruz BiotechnologyEvidence 65

alpha-synuclein (211)

Cited in 13 papers
#sc-12767
View Evidence →
Bio-RadEvidence 71

2-Mercaptoethanol (BME)

Cited in 5 papers
#1610710
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 60

PathScan® Total HER4/ErbB4 Sandwich ELISA Kit

Cited in 7 papers
#13010$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 69

ARH3 (E8A6G) Rabbit Monoclonal Antibody

Cited in 6 papers
#32205$175,376
View Evidence →
Thermo Fisher Scientific

Rabbit Anti-Alexa Fluor 488 Polyclonal Antibody, Unconjugated

Cited in 6 papers
#A-11094 (also A11094)
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt

Cited in 14 papers
#MAB369
View Evidence →
Santa Cruz BiotechnologyEvidence 65

alpha-synuclein (211)

Cited in 13 papers
#sc-12767
View Evidence →
BD BiosciencesEvidence 60

a-Synuclein

Cited in 13 papers
#610787
View Evidence →